ABIDEM LIMITED

Company number 13019467 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

ABIDEM LIMITED - Analysis Report

Company Number: 13019467

Analysis Date: 2025-07-20 14:30 UTC

Financial Health Assessment Report for ABIDEM LIMITED


1. Financial Health Score: D (Poor)

Explanation:
ABIDEM LIMITED exhibits symptoms of financial distress as indicated by negative net current assets and net liabilities as of the latest financial year, which is a concerning sign for a micro-entity. The company has deteriorated from a marginally positive net asset position last year to a negative position this year, suggesting worsening liquidity and solvency challenges.


2. Key Vital Signs

Metric 2024 (£) 2023 (£) Interpretation
Current Assets 2,948 389 Healthy increase in liquid and short-term assets
Current Liabilities 3,632 388 Sharp increase in short-term obligations
Net Current Assets -684 1 Negative working capital indicates cash flow stress
Total Net Assets (Liabilities) -684 1 Net liabilities signal insolvency risk
Share Capital 1 1 Minimal equity base; limited capital cushion
Employees 0 0 No employees; likely low operating complexity

Interpretation of Vital Signs:

  • The company’s current assets have increased substantially, which is a positive sign indicating more cash or receivables on hand.
  • However, current liabilities have increased disproportionately, leading to negative net current assets (working capital), a critical symptom of liquidity strain.
  • The shift from positive to negative net assets (shareholders’ funds) signals possible erosion of the company’s financial foundation, potentially raising doubts about solvency.
  • The minimal share capital and no employees reflect a very small-scale operation, limiting resources to manage financial shocks.

3. Diagnosis

ABIDEM LIMITED is exhibiting symptoms of financial distress, primarily liquidity and solvency issues, despite being a micro-entity with minimal operational complexity. The company’s working capital has shifted into negative territory, indicating that short-term debts exceed short-term assets, and the net asset position has turned negative, suggesting that total liabilities now exceed total assets.

This condition is akin to a patient whose vital signs (cash flow and equity) are deteriorating, signaling an urgent need for intervention to avoid financial collapse. Without sufficient reserves or capital infusion, the company risks inability to meet its creditor demands, which could lead to insolvency or forced restructuring.


4. Recommendations

  • Cash Flow Management:
    Immediate focus on improving liquidity is essential. The company should accelerate collection of receivables, delay non-essential payments where possible, and closely monitor cash flow to ensure ongoing operational viability.

  • Cost Control:
    Assess and minimize expenses rigorously to reduce current liabilities growth. Even with no employees, other operating costs should be managed tightly.

  • Capital Injection:
    Consider raising additional equity capital or securing short-term financing to restore net asset value and provide a cushion for operational needs.

  • Debt Restructuring:
    Engage with creditors proactively to negotiate extended payment terms or refinancing options to ease short-term financial pressure.

  • Financial Planning & Monitoring:
    Implement regular financial reviews and forecasting to detect early signs of distress and allow timely corrective action.

  • Seek Professional Advice:
    Given the negative net asset position, consulting with a financial advisor or insolvency practitioner may be prudent to explore restructuring options to ensure long-term survival.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.